It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Corneal innervation plays a major role in the pathobiology of diabetic corneal disease. However, innervation impact has mainly been investigated in the context of diabetic epitheliopathy and wound healing. Further studies are warranted in the corneal stroma-nerve interactions. This study unravels the nerve influence on corneal stroma metabolism. Corneal stromal cells were isolated from healthy (HCFs) and diabetes mellitus (Type1DM and Type2 DM) donors. Cells were cultured on polycarbonate membranes, stimulated by stable Vitamin C, and stroma-only and stroma-nerve co-cultures were investigated for metabolic alterations. Innervated compared to stroma-only constructs exhibited significant alterations in pyrimidine, glycerol phosphate shuttle, electron transport chain and glycolysis. The most highly altered metabolites between healthy and T1DMs innervated were phosphatidylethanolamine biosynthesis, and pyrimidine, methionine, aspartate metabolism. Healthy and T2DMs main pathways included aspartate, glycerol phosphate shuttle, electron transport chain, and gluconeogenesis. The metabolic impact on T1DMs and T2DMs was pyrimidine, purine, aspartate, and methionine. Interestingly, the glucose-6-phosphate and oxaloacetate was higher in T2DMs compared to T1DMs. Our in vitro co-culture model allows the examination of key metabolic pathways corresponding to corneal innervation in the diabetic stroma. These novel findings can pave the way for future studies to fully understand the metabolic distinctions in the diabetic cornea.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 University of Oklahoma Health Sciences Center, Department of Physiology, Oklahoma City, USA (GRID:grid.266902.9) (ISNI:0000 0001 2179 3618)
2 University of North Texas Health Science Center, North Texas Eye Research Institute, Fort Worth, USA (GRID:grid.266871.c) (ISNI:0000 0000 9765 6057); University of North Texas Health Science Center, Department of Pharmaceutical Sciences, Fort Worth, USA (GRID:grid.266871.c) (ISNI:0000 0000 9765 6057)
3 University of Oklahoma Health Sciences Center, Department of Physiology, Oklahoma City, USA (GRID:grid.266902.9) (ISNI:0000 0001 2179 3618); Harold Hamm Oklahoma Diabetes Center, Oklahoma City, USA (GRID:grid.266902.9)
4 University of North Texas Health Science Center, North Texas Eye Research Institute, Fort Worth, USA (GRID:grid.266871.c) (ISNI:0000 0000 9765 6057); University of North Texas Health Science Center, Department of Pharmaceutical Sciences, Fort Worth, USA (GRID:grid.266871.c) (ISNI:0000 0000 9765 6057); University of North Texas Health Science Center, Department of Pharmacology and Neuroscience, Fort Worth, USA (GRID:grid.266871.c) (ISNI:0000 0000 9765 6057)